Cencora, Inc. (COR) P/E Ratio History
Historical price-to-earnings valuation from 1995 to 2026
Loading P/E history...
COR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Cencora, Inc. (COR) trades at a price-to-earnings ratio of 38.4x, with a stock price of $305.90 and trailing twelve-month earnings per share of $8.32.
The current P/E is 62% above its 5-year average of 23.7x. Over the past five years, COR's P/E has ranged from a low of 11.6x to a high of 40.6x, placing the current valuation at the 90th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, COR trades at a 73% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 171.0x.
Relative to the broader market, COR commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our COR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
COR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $98B | 31.1 | 0.80 | +15% | |
| $46B | 30.5 | - | +87%Best | |
| $9B | 22.7 | 7.22 | +7% | |
| $103B | 58.1 | - | -62% | |
| $330B | 27.5 | - | -15% | |
| $73B | 12.4Lowest | - | +83% | |
| $96B | 15.1 | 0.72Best | +29% | |
| $21B | 21.8 | - | +14% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
COR Historical P/E Data (1995–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | Wed Dec 31 2025 00:00:00 GM | $337.75 | $8.32 | 40.6x | +26% |
| FY2025 Q4 | $312.53 | $7.95 | 39.3x | +22% | |
| FY2025 Q3 | Mon Jun 30 2025 00:00:00 GM | $299.85 | $9.72 | 30.9x | -5% |
| FY2025 Q2 | Mon Mar 31 2025 00:00:00 GM | $278.09 | $8.62 | 32.3x | -0% |
| FY2025 Q1 | $224.68 | $7.03 | 32.0x | -1% | |
| FY2024 Q4 | Mon Sep 30 2024 00:00:00 GM | $225.08 | $7.51 | 30.0x | -7% |
| FY2024 Q3 | Sun Jun 30 2024 00:00:00 GM | $225.30 | $9.21 | 24.5x | -24% |
| FY2024 Q2 | Sun Mar 31 2024 00:00:00 GM | $242.99 | $9.14 | 26.6x | -18% |
| FY2024 Q1 | Sun Dec 31 2023 00:00:00 GM | $205.38 | $9.18 | 22.4x | -31% |
| FY2023 Q4 | Sat Sep 30 2023 00:00:00 GM | $179.97 | $8.53 | 21.1x | -35% |
| FY2023 Q3 | Fri Jun 30 2023 00:00:00 GM | $192.43 | $8.21 | 23.4x | -27% |
| FY2023 Q2 | Fri Mar 31 2023 00:00:00 GM | $160.11 | $7.78 | 20.6x | -36% |
Average P/E for displayed period: 32.3x
Full COR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See COR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOR — Frequently Asked Questions
Quick answers to the most common questions about buying COR stock.
Is COR stock overvalued or undervalued?
COR trades at 38.4x P/E, above its 5-year average of 23.7x. The 90th percentile ranking indicates a premium to historical valuation.
How does COR's valuation compare to peers?
Cencora, Inc. P/E of 38.4x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is COR's PEG ratio?
COR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1995-2026.